Topiramate Tablet
Product Images NDC 43063-735

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 43063-735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063735 Label (43063735)

This is a description of a medication called Topiramate in the form of 60 white round tablets, each containing USP 25mg. It provides instructions to take the tablet(s) multiple times per day and warns to keep it out of reach of children. It also includes the ReOrder number, LOT, and expiration date. The packaging insert offers dosage and storage instructions. In case of side effects, it is advisable to contact a doctor or the FDA. The remaining text is not legible.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02

The text appears to show a graph presenting cumulative rates for time to the first seizure for two groups of individuals: one group treated with Topiramate 50 mg/day (N=234) and the other group treated with Topiramate 400 mg/day (N=236). The X-axis represents time in days, ranging from 0 to 500, and the Y-axis represents the cumulative rate of the first seizure.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03

The text indicates the change in the average monthly migraine period rate during a double-blind phase of a study with Topamax. The dosage used in the study was either 100 or 200 milligrams per day. The text also shows significant improvements in the migraine rate, represented by a statistically significant p-value.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.